STABLE PHARMACEUTICAL COMPOSITION OF TNFR:FC FUSION PROTEIN.

摘要

The present invention relates to the stable pharmaceutical compositions comprising tumor necrosis factor receptor Fc fusion protein (TNFR:Fc). More particularly, it relates to the stable pharmaceutical compositions comprising tumor necrosis factor receptor Fc fusion protein (TNFR:Fc), phosphate - citrate buffer. It also relates to the methods of manufacturing the composition, method of administration and kits containing the same.